Showing results (11-20 of 633) with videos related to
Sort By:
Pageof 64
Expert Opinion on Emerging Drugs|August 28, 2009
Antigen-specific therapies in multiple sclerosisPaul S Giacomini, Amit Bar-OrCurrent Opinion in Neurology|April 2, 2016
Central nervous system inflammation across the age spanAmit Bar-Or, Jack P AntelClinical Immunology (Orlando, Fla.)|April 1, 2011
Laquinimod in multiple sclerosisPaul S Giacomini, Amit Bar-OrScientific Reports|September 10, 2020
Multiplexed detection and isolation of viable low-frequency cytokine-secreting human B cells using cytokine secretion assay and flow cytometry (CSA-Flow)Ayman Rezk, Rui Li, Amit Bar-OrArquivos De Neuro-Psiquiatria|April 9, 2008
Beta interferons in clinically isolated syndromes: a meta-analysisAilton Melo, Bernardo Rodrigues, Amit Bar-OrExpert Review of Clinical Immunology|May 19, 2010
B-cell subsets: cellular interactions and relevance in multiple sclerosisClaudia J Calder, Martin Duddy, Amit Bar-OrJournal of Neurology|November 19, 2004
What do we know about the mechanism of action of disease-modifying treatments in MS?Hans-Peter Hartung, Amit Bar-Or, Yannis ZoukosNeurology(R) Neuroimmunology & Neuroinflammation|May 17, 2020
COVID-19 and MS disease-modifying therapiesJoseph R Berger, Rachel Brandstadter, Amit Bar-OrJournal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Distinct profiles of human B cell effector cytokines: a role in immune regulation?Martin E Duddy, Andrea Alter, Amit Bar-OrNature Immunology|June 22, 2018
Reassessing B cell contributions in multiple sclerosisRui Li, Kristina R Patterson, Amit Bar-OrPageof 64